2 results
Approved WMOCompleted
The objective of the study is to determine whether 11C-metomidate PET can differentiate between BAH and APA./PAH
Approved WMOCompleted
Primary• To evaluate the progression free survival (PFS), based on independent radiologic review (IRR), of ASP8273 compared to erlotinib or gefitinib in patients with locally advanced, metastatic or unresectable stage IIIB/IV adenocarcinoma non-…